DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine

2017 ◽  
Vol 28 ◽  
pp. 175-176 ◽  
Author(s):  
Venkatalakshmi Penchilaiya ◽  
Pooja Patnaik Kuppili ◽  
K. Preeti ◽  
Balaji Bharadwaj
Keyword(s):  
Sodium Valproate ◽  
Drug Hypersensitivity ◽  
Hypersensitivity Syndrome ◽  
Dress Syndrome ◽  
Drug Hypersensitivity Syndrome

scholarly journals High Procalcitonin in a Patient with Drug Hypersensitivity Syndrome

2009 ◽  
Vol 48 (16) ◽  
pp. 1471-1474 ◽  
Author(s):  
Branka Bonaci-Nikolic ◽  
Ivica Jeremic ◽  
Milos Nikolic ◽  
Sladjana Andrejevic ◽  
Lidija Lavadinovic
Keyword(s):  
Drug Hypersensitivity ◽  
Hypersensitivity Syndrome ◽  
Drug Hypersensitivity Syndrome

scholarly journals Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

Reumatismo ◽  
2011 ◽  
Vol 61 (1) ◽  
Author(s):  
M. Gutierrez ◽  
E. Filippucci ◽  
L. Bugatti ◽  
C. Bertolazzi ◽  
W. Grassi
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Hypersensitivity ◽  
Hypersensitivity Syndrome ◽  
Drug Hypersensitivity Syndrome

Toxic Epidermal Necrolysis Caused by Pentamidine; Tigecycline-Induced Pancreatitis; Minocycline-Induced Drug Hypersensitivity Syndrome Followed by Autoimmune Sequelae; Fatal Hypersensitivity Myocarditis Associated with Azithromycin; Altered Mental Status Caused by High Levels of Phenytoin; Pseudogout after Polyethylene Glycol Bowel Cleansing; Severe Pseudomembranous Colitis after Moxifloxacin Use: A Case Series

2009 ◽  
Vol 44 (4) ◽  
pp. 293-296
Author(s):  
Joel Shuster
Keyword(s):  
Polyethylene Glycol ◽  
Pseudomembranous Colitis ◽  
Drug Hypersensitivity ◽  
Case Series ◽  
Altered Mental Status ◽  
Hypersensitivity Syndrome ◽  
Drug Reactions ◽  
Bowel Cleansing ◽  
The Us ◽  
Drug Hypersensitivity Syndrome

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.

Sign in / Sign up

Export Citation Format

Share Document